Evidence for NK cell subsets based on chemokine receptor expression

Journal of Immunology

Volumn 177, Issue 11, 2006, Pages 7833-7840

  Berahovich, Robert D ^a   Lai, Nu L ^a   Wei, Zheng ^a   Lanier, Lewis L ^b   Schall, Thomas J ^a  

^a ChemoCentryx Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR5; CHEMOKINE RECEPTOR CXCR6; CX3C CHEMOKINE; INTERLEUKIN 8; STROMAL CELL DERIVED FACTOR 1ALPHA;

ARTICLE; CELLULAR IMMUNITY; CHEMOTAXIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INNATE IMMUNITY; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 33751569559     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.11.7833     Document Type: Article

References (21)

1. Maghazachi, A. A. 2005. Compartmentalization of human natural killer cells. Mol. Immunol. 42: 523-529.
2. Morris, M. A., and K. Ley. 2004. Trafficking of natural killer cells. Curr. Mol. Med. 4: 431-438.
3. Robertson, M. J. 2002. Role of chemokines in the biology of natural killer cells. J. Leukocyte Biol. 71: 173-183.
4. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101: 3052-3057.
5. bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J. Immunol. 173: 6418-6426.
6. Ferlazzo, G., D. Thomas, S. L. Lin, K. Goodman, B. Morandi, W. A. Muller, A. Moretta, and C. Munz. 2004. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172: 1455-1462.
7. +high stage and effector functions. J. Immunol. 172: 88-96.
8. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol. 166: 6477-6482.
9. Inngjerdingen, M., B. Damaj, and A. A. Maghazachi. 2001. Expression and regulation of chemokine receptors in human natural killer cells. Blood 97: 367-375.
10. Robertson, M. J., K. J. Cochran, C. Cameron, J. M. Le, R. Tantravahi, and J. Ritz. 1996. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 24: 406-415.
11. Yagita, M., C. L. Huang, H. Umehara, Y. Matsuo, R. Tabata, M. Miyake, Y. Konaka, and K. Takatsuki. 2000. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia 14: 922-930.
12. Gong, J. H., G. Maki, and H. G. Klingemann. 1994. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 8: 652-658.
13. + T cells upon CD226 engagement. J. Immunol. 175: 4914-4926.
14. Cook, D. N., D. M. Prosser, R. Forster, J. Zhang, N. A. Kuklin, S. J. Abbondanzo, X. D. Niu, S. C. Chen, D. J. Manfra, M. T. Wiekowski, et al. 2000. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12: 495-503.
15. Lukacs, N. W., D. M. Prosser, M. Wiekowski, S. A. Lira, and D. N. Cook. 2001. Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation. J. Exp. Med, 194: 551-555.
16. Kim, C. H., E. J. Kunkel, J. Boisvert, B. Johnston, J. J. Campbell, M. C. Genovese, H. B. Greenberg, and E. C. Butcher. 2001. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J. Clin. Invest. 107: 595-601.
17. + lymphocytes to inflamed liver. J. Immunol. 174: 277-283.
18. Muller, G., and M. Lipp. 2003. Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking. Microcirculation 10: 325-334.
19. Muller, G., U. E. Hopken, H. Stein, and M. Lipp. 2002. Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors. J. Leukocyte Biol. 72: 1-8.
20. Carlsen, H. S., E. S. Baekkevold, F. E. Johansen, G. Haraldsen, and P. Brandtzaeg. 2002. B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut 51: 364-371.
21. Aust, G., D. Sittig, L. Becherer, U. Anderegg, A. Schutz, P. Lamesch, and E. Schmucking. 2004. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases. Eur. J. Endocrinol. 150: 225-234.